about
Update in genetic susceptibility in melanomaTERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and SpainBiochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma: A Web-Based International Dermoscopy Society Study.Growth-Curve Modeling of Nevi With a Peripheral Globular PatternSerum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Dermoscopic rosettes as a clue for pigmented incipient melanoma.Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.Clinical and Histopathological Characteristics between Familial and Sporadic Melanoma in Barcelona, Spain.Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanomaHigh nevus counts confer a favorable prognosis in melanoma patients.Mutational status of naevus-associated melanomas.Genetic counseling in melanoma.Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?Genetic alterations in RAS-regulated pathway in acral lentiginous melanomaEffect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.Clinical and dermoscopic features of atypical Spitz tumors: A multicenter, retrospective, case-control study.Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions.Desmoplastic melanoma on the nose: electrochemotherapy as an alternative treatment to local advanced disease.Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy.Noninvasive imaging for nonmelanoma skin cancer.Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis.Practice Gaps in Dermatology: Melanocytic Lesions and Melanoma.Discriminating Nevi from Melanomas: Clues and Pitfalls.The Role of Reflectance Confocal Microscopy in Clinical Trials for Tumor Monitoring.Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab.Non-invasive management of non-melanoma skin cancer in patients with cancer predisposition genodermatosis: a role for confocal microscopy and photodynamic therapy.Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma.In vivo reflectance confocal microscopy of equivocal melanocytic lesions detected by digital dermoscopy follow-up.Patterns of distribution of giant congenital melanocytic nevi (GCMN): The 6B rule.
P50
Q26778756-181AD4E4-EB6A-4C18-9E4F-7E4F224B6E62Q27853068-D5FBB0B0-7A8E-4D99-AB10-87F2F77B9FEEQ27853071-383A4C83-2C57-4B41-9A7F-BCDD8D607139Q30384693-B96070BD-1A9A-482C-ADFF-7D9981947410Q33370019-271C8CE4-0227-4CE9-A652-17AA626F8DF4Q33746014-C6C86B74-6822-48ED-9E4C-F07CD4321638Q33832930-37DC7A7F-9075-4F48-9A32-DEE627EA4804Q34588331-5DB14340-56FA-475C-B1F8-C7ABF0894189Q34602917-656B9A99-1385-4398-AB5B-1324F34DDDFEQ35072213-CC85C8E0-DE89-4ACE-8590-0020E25A6844Q35180844-00A0545D-4FAF-4DCC-9907-FFCE3B1085BFQ35446785-0F26E762-AC60-474C-9014-77FC2310131DQ35549114-13914A6A-9E5C-4615-A26D-D7E17E98D74FQ35855182-2828CA5F-5DFF-49E8-B2BB-7641731794AFQ36095004-630B6814-5F63-47B8-9FFA-B9FABDD39C16Q36314787-13B1B315-BAFA-4BFB-86E7-7B33627B24B5Q36578597-5F6FD7FF-D990-4F2A-A5E5-94F6EE0A24F4Q36584447-FA79BE38-CFB9-4FD1-93B5-9B40B653B804Q36622333-B3248B2D-0C32-4019-8C58-9321FF40DA5CQ36725903-0FC57C63-A009-40BE-B6D8-E9581D1D5D34Q37083946-8064594E-40D3-4698-80DE-EF68BE95BD27Q37392769-C71D8F3B-4AD5-4BCA-A37F-BEE18E0154B2Q37699008-29D3B2C3-181F-414A-8C76-830FBA361C71Q38090728-85B6D873-ABA5-414C-B3C2-ECF0F822F3D2Q38741718-549435EB-99FB-4A25-9A43-AC0BB4197A84Q38768293-D843929C-7AC5-4A6F-8806-C431E31239C8Q38868933-79F5CC74-B30A-4F62-B948-50E6334CF30CQ38882355-2F35A007-D037-4921-B9CE-EFE93C3B41C9Q38969370-C85A50CF-3A67-40FE-9117-365EE414236FQ38969414-25BD313D-01F0-4928-BFA1-817FA2906993Q39180116-6EC1BD21-95DC-46F4-8712-B4B246B50D94Q39436788-B786BC75-8044-4237-8305-64F230A0061CQ39685772-E38332C2-4CBD-47B3-B08A-53FFA5E1FE3CQ39821273-42775308-D953-46E7-B62E-0C96F2D01E00Q39827769-7EB53DBD-3B90-4E77-9A4B-28E9926E8A34Q40229413-C3F25057-8A7B-47D3-B724-AC8D0A5FB371Q40248504-220EFDF2-9987-4132-9BD6-1CCF6ABDA9CBQ40254885-396515F9-07C4-480B-BEFE-2B8E333C3A47Q40262407-4D5F8CCF-237C-4B2B-BE62-AC1A5BFB0A2AQ40282083-60FA0221-EC99-4940-94B8-F573A75FF48C
P50
description
hulumtuese
@sq
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Carrera
@ast
Cristina Carrera
@en
Cristina Carrera
@en-gb
Cristina Carrera
@es
Cristina Carrera
@nl
Cristina Carrera
@sl
type
label
Cristina Carrera
@ast
Cristina Carrera
@en
Cristina Carrera
@en-gb
Cristina Carrera
@es
Cristina Carrera
@nl
Cristina Carrera
@sl
altLabel
CRISTINA CARRERA
@en
prefLabel
Cristina Carrera
@ast
Cristina Carrera
@en
Cristina Carrera
@en-gb
Cristina Carrera
@es
Cristina Carrera
@nl
Cristina Carrera
@sl
P106
P1153
36870183300
P21
P31
P496
0000-0003-1608-8820